Las Vegas, NV -- (SBWIRE) -- 09/27/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Cereplast Inc(OTCMKTS:CERP), Fab Universal Corp(NYSEMKT:FU), Trina Solar Limited (ADR)(NYSE:TSL), Galena Biopharma Inc(NASDAQ:GALE)
Cereplast Inc(OTCMKTS:CERP) complete the day at $0.0131. The total number of shares changed hands during the day was 10.64million. After opening at $0.01, the stock hit as high as $0.01. However, it traded between $0.01and $0.30 over the last twelve months. Cereplast, Inc. develops and commercializes bio-based resins. It provides Cereplast Compostables resins, which are compostable, bio-based, and ecologically sound substitutes for petroleum-based plastics targeting compostable bags, single-use food service products, and packaging applications.
Can Investors Bet on CERP after this News update? Find out in this Research Report
Fab Universal Corp(NYSEMKT:FU) closed yesterday at $8.67, a -10.62% decrease. Around 9.55 million shares were traded, beating an-average trading volume of 995,755.00 shares. The company is now valued at around $180.39 million. FAB Universal Corp. engages in the distribution of digital entertainment products and services worldwide.
Has FU Found The Bottom And Ready To Gain Momentum? Find Out Here
Trina Solar Limited (ADR)(NYSE:TSL) moved +1.02 percent higher at $12.84 and traded between $12.72 and $13.66 after opening the day at $12.85. Its performance over the last five days remained +9.56%, which stands at +38.06% for a month. Going back further than one month, 1-year performance after recent close was +195.85%. Trina Solar Limited, an integrated solar-power products manufacturer, engages in the design, development, manufacture, and sale of photovoltaic (PV) modules worldwide.
Will TSL Continue To Move Higher? Find Out Here
Galena Biopharma Inc(NASDAQ:GALE)’s shares rose, gaining +7.22 percent to close at $2.08. The stock is up around +35.95% this year and +14.92% for the last 12 months. Around 6.76 million shares changed hands yesterday, higher from an-average trading volume of 2.59 million shares. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
Why Should Investors Buy GALE After The Recent Gain? Just Go Here and Find Out
About Value Stock Pick
Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks.
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)